|
시장보고서
상품코드
2055058
패혈증 진단 시장 : 제품 유형별, 진단법별, 병원체별, 기술별, 최종사용자별, 지역별Sepsis Diagnostics Market, By Product Type, By Method, By Pathogen, By Technology, By End User, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
패혈증 진단 시장은 2026년에 11억 1,840만 달러로 추정되며, 2033년까지 21억 9,330만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 10.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 11억 1,840만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.10% | 2033년 시장 규모 예측 : | 21억 9,330만 달러 |
패혈증이란 감염에 대한 신체의 반응이 전신에 염증 반응을 일으키는 상태를 말합니다. 면역계는 병원체를 체외로 배출하기 위해 혈류에 염증성 화학 물질을 방출하지만, 이러한 화학 물질이 연쇄적인 반응을 일으켜 장기 손상을 초래하고, 심지어 사망에 이를 수도 있습니다. 패혈증의 증상으로는 저혈압, 의식 혼탁, 발열, 심박수 증가, 호흡곤란 등이 있습니다. 패혈증은 세균, 바이러스, 진균 등의 감염성 병원체에 의해 유발될 수 있습니다. 패혈증의 위험을 높이는 요인으로는 고령, 당뇨병, 간 질환, 항생제 사용, 카테터와 같은 침습적 의료기기의 사용 등이 있습니다.
시장 역학
시장에 진출한 각 기업은 패혈증에 대한 보다 효율적인 진단 시스템을 개발하기 위한 임상시험을 진행 중이며, 이는 예측 기간 동안 시장 성장에 기여할 가능성이 있습니다. 예를 들어, 2021년 2월, 미국 캘리포니아주에 본사를 둔 진단약 기업인 Inflammatix, Inc.는 자사 제품인 ‘HostDx Sepsis’에 대한 1,500명을 대상으로 한 임상시험을 시작했습니다. 이 시험은 2022년 11월까지 완료될 예정입니다. 본 임상시험에서는 패혈증이 의심되는 환자의 진단 및 예후 판정에 있어 ‘HostDx Sepsis’ 진단 검사의 성능을 검증합니다.
시장에 진출한 기업들은 유통 체계를 강화하기 위해 타사와의 제휴를 통해 세계 사업 확장을 추진하고 있으며, 이는 전 세계 패혈증 진단 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2021년 5월에는 BARDA(생물의학선도연구개발국)와 미국 캘리포니아주에 본사를 둔 생물의학 검사 솔루션 제공업체인 벡만 콜터(Beckman Coulter)사가, 코로나19 환자의 패혈증 조기 발견을 위한 진단 알고리즘 개발을 목표로 전략적 제휴를 체결했습니다.
본 조사의 주요 특징
- 본 보고서는 전 세계 패혈증 진단 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도로 하여 2026년부터 2033년까지의 예측 기간 동안 시장 규모 및 연평균 성장률(CAGR)을 제시하고 있습니다. 또한, 각 부문별 잠재적 수익 기회를 도출하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 보고서에서는 다음 매개변수를 바탕으로 전 세계 패혈증 진단 시장의 주요 기업 프로파일을 분석했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계 패혈증 진단 시장 보고서’는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 패혈증 진단 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 패혈증 진단 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 패혈증 진단 시장 : 방법별, 2021년-2033년
제6장 세계의 패혈증 진단 시장 : 병원체별, 2021년-2033년
제7장 세계의 패혈증 진단 시장 : 기술별, 2021년-2033년
제8장 세계의 패혈증 진단 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 패혈증 진단 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.06.22Sepsis Diagnostics Market is estimated to be valued at USD 1,118.4 Mn in 2026 and is expected to reach USD 2,193.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,118.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.10% | 2033 Value Projection: | USD 2,193.3 Mn |
Sepsis is a condition wherein the body's response to infection triggers an inflammation reaction throughout the body. The immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body, but instead these chemicals cause a cascade of reactions that result in organ damage and may be fatal. A few of the symptoms of sepsis include low blood pressure, mental confusion, fever, an increased heart rate, and difficulty breathing. Sepsis may be caused by infectious agents such as bacteria, viruses, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, the use of antibiotics, and the use of invasive medical devices such as catheters.
Market Dynamics
Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2021, Inflammatix, Inc., a California, U.S. based diagnostics company, initiated a clinical trial study for their product HostDx Sepsis with 1500 participants, which is expected to be completed by November 2022. This clinical study investigates the performance of the HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.
Market players are involved in expanding their presence globally by entering into collaboration with other companies in order to enhance distribution, which is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2021, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a California, U.S. based biomedical testing solutions provider, entered into a strategic collaboration for the development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.
Key features of the study
- This report provides an in-depth analysis of the global sepsis diagnostics market and provides market size (USD Mn) and compound annual growth rate (CAGR) for the forecast period 2026 - 2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global sepsis diagnostics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include BioMerieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global sepsis diagnostics marketreport caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sepsis diagnostics market.
Market Segmentation
- Global Sepsis Diagnostics Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Blood Culture Media
- Assays & Reagents
- Instruments
- Software
- Global Sepsis Diagnostic Market, By Method (Revenue, USD Mn, 2021 - 2033)
- Automated Diagnostics
- Conventional Diagnostics
- Global Sepsis Diagnostics Market, By Pathogen (Revenue, USD Mn, 2021 - 2033)
- Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Fungal Sepsis
- Others
- Global Sepsis Diagnostic Market, By Technology (Revenue, USD Mn, 2021 - 2033)
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
- Global Sepsis Diagnostic Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes
- Global Sepsis Diagnostic Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- BioMerieux SA
- Thermo Fisher Scientific
- Abbott Laboratories
- Roche Diagnostics AG
- Luminex Corporation
- CytoSorbents Corporation
- Becton Dickinson Company
- Danaher Corporation
- Axis-Shield Diagnostics
- T2 Biosystems
- EKF Diagnostics
- Immunexpress Inc.
- Response Biomedical Corporation
- Bruker Corporation
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Method
- Market Snippet, By Pathogen
- Market Snippet, By Technology
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Sepsis Diagnostics Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Blood Culture Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Assays & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
5. Global Sepsis Diagnostics Market, By Method, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Automated Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Conventional Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
6. Global Sepsis Diagnostics Market, By Pathogen, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bacterial Sepsis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Gram-Negative Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Fungal Sepsis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
7. Global Sepsis Diagnostics Market, By Technology, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Sepsis Diagnostics Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pathology & Reference Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Research Laboratories & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Sepsis Diagnostics Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Method, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Pathogen, 2021-2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (USD Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- BioMerieux SA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Roche Diagnostics AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Luminex Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CytoSorbents Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Becton Dickinson Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Axis-Shield Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- T2 Biosystems
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- EKF Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Immunexpress Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Response Biomedical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bruker Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- BioMerieux SA
11. Section
- References
- Research Methodology
- About us and Sales Contact
